1. Home
  2. BITF vs ANIP Comparison

BITF vs ANIP Comparison

Compare BITF & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bitfarms Ltd.

BITF

Bitfarms Ltd.

HOLD

Current Price

$2.88

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$77.13

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BITF
ANIP
Founded
2017
2001
Country
Canada
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BITF
ANIP
Price
$2.88
$77.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$3.67
$105.83
AVG Volume (30 Days)
39.0M
414.8K
Earning Date
11-13-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.67
Revenue
$276,409,000.00
$826,880,000.00
Revenue This Year
$47.67
$44.06
Revenue Next Year
$0.20
$9.06
P/E Ratio
N/A
$46.97
Revenue Growth
94.98
48.87
52 Week Low
$0.67
$52.74
52 Week High
$6.60
$99.50

Technical Indicators

Market Signals
Indicator
BITF
ANIP
Relative Strength Index (RSI) 53.59 31.39
Support Level $2.32 $80.27
Resistance Level $2.95 $80.29
Average True Range (ATR) 0.21 2.32
MACD 0.06 -0.24
Stochastic Oscillator 90.14 4.53

Price Performance

Historical Comparison
BITF
ANIP

About BITF Bitfarms Ltd.

Bitfarms Ltd engaged in the cryptocurrency Mining industry mainly consists of selling its computational power used for hashing calculations for cryptocurrency mining in multiple jurisdictions. Its geographic operations are currently located in Canada, the United States, Argentina. It owns and operates server farms comprised of computers designed to validate transactions on the Bitcoin Blockchain.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: